Skip to main content
Article
Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer
Journal of Radiation Oncology (2012)
  • Michael Chuong
  • Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R
Publication Date
2012
Citation Information
Michael Chuong and Springett GM, Weber JM, Klapman J, Vignesh S, Hodul PJ, Malafa MP, Leuthold S, Hoffe SE, Shridhar R. "Induction gemcitabine-based chemotherapy and neoadjuvant stereotactic body radiation therapy achieve high margin-negative resection rates for borderline resectable pancreatic cancer" Journal of Radiation Oncology Vol. 1 Iss. 3 (2012) p. 273 - 281
Available at: http://works.bepress.com/michael-chuong/66/